Juva Life Inc (JUVAF)
0.0319
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
Juva Life Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 12.56M |
| May 08, 2024 | 12.65M |
| May 07, 2024 | 12.71M |
| May 06, 2024 | 12.17M |
| May 03, 2024 | 12.57M |
| May 02, 2024 | 12.17M |
| May 01, 2024 | 12.17M |
| April 30, 2024 | 12.25M |
| April 29, 2024 | 11.52M |
| April 26, 2024 | 10.79M |
| April 25, 2024 | 10.83M |
| April 24, 2024 | 10.81M |
| April 23, 2024 | 10.87M |
| April 22, 2024 | 10.53M |
| April 19, 2024 | 10.41M |
| April 18, 2024 | 11.63M |
| April 17, 2024 | 12.25M |
| April 16, 2024 | 11.93M |
| April 15, 2024 | 11.64M |
| April 12, 2024 | 11.24M |
| April 11, 2024 | 11.11M |
| April 10, 2024 | 11.02M |
| April 09, 2024 | 10.90M |
| April 08, 2024 | 11.04M |
| April 05, 2024 | 10.97M |
| Date | Value |
|---|---|
| April 04, 2024 | 11.00M |
| April 03, 2024 | 10.81M |
| April 02, 2024 | 10.86M |
| April 01, 2024 | 10.96M |
| March 28, 2024 | 10.61M |
| March 27, 2024 | 10.12M |
| March 26, 2024 | 10.56M |
| March 25, 2024 | 10.35M |
| March 22, 2024 | 10.04M |
| March 21, 2024 | 9.924M |
| March 20, 2024 | 10.28M |
| March 19, 2024 | 9.86M |
| March 18, 2024 | 10.20M |
| March 15, 2024 | 9.711M |
| March 14, 2024 | 9.875M |
| March 13, 2024 | 10.28M |
| March 12, 2024 | 9.940M |
| March 11, 2024 | 10.02M |
| March 08, 2024 | 9.957M |
| March 07, 2024 | 9.957M |
| March 06, 2024 | 10.12M |
| March 05, 2024 | 10.12M |
| March 04, 2024 | 10.27M |
| March 01, 2024 | 10.28M |
| February 29, 2024 | 10.11M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.407M
Minimum
Feb 21 2024
242.87M
Maximum
Jan 21 2021
36.82M
Average
25.43M
Median
Enterprise Value Benchmarks
| Rimrock Gold Corp | -- |
| InMed Pharmaceuticals Inc | -7.873M |
| Venus Concept Inc | 74.38M |
| CEN Biotech Inc | -- |
| Lucy Scientific Discovery Inc | 2.324M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.466M |
| Revenue (Quarterly) | 1.725M |
| Total Expenses (Quarterly) | 2.456M |
| EPS Diluted (Quarterly) | -0.01 |
| Gross Profit Margin (Quarterly) | 21.44% |
| Profit Margin (Quarterly) | -85.00% |